EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity

Michael J Hollander, Stacy A Malaker, Nicholas M Riley, Idalia Perez, Nayla M Abney, Melissa A Gray, Julia E Maxson, Jennifer R Cochran, Carolyn R Bertozzi

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.104755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Michael J Hollander und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Stanford University, Stanford, California, USA; Department of Chemistry and Sarafan ChEM-H, Stanford University, Stanfo…. Hauptthemen laut MEDLINE: Leukemia, Neutrophilic, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Howard Hughes Medical Institute, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The colony-stimulating factor 3 receptor (CSF3R) controls the growth of neutrophils, the most abundant type of white blood cell. In healthy neutrophils, signaling is dependent on CSF3R binding to its ligand, CSF3. A single amino acid mutation in CSF3R, T618I, instead allows for constitutive, ligand-independent cell growth and leads to a rare type of cancer called chronic neutrophilic leukemia. However, the disease mechanism is not well understood. Here, we investigated why this threonine to isoleucine substitution is the predominant mutation in chronic neutrophilic leukemia and how it leads to uncontrolled neutrophil growth. Using protein domain mapping, we demonstrated that the single CSF3R domain containing residue 618 is sufficient for ligand-independent activity. We then applied an unbiased mutational screening strategy focused on this domain and found that activating mutations are enriched at sites normally occupied by asparagine, threonine, and serine residues-the three amino acids which are commonly glycosylated. We confirmed glycosylation at multiple CSF3R residues by mass spectrometry, including the presence of GalNAc and Gal-GalNAc glycans at WT threonine 618. Using the same approach applied to other cell surface receptors, we identified an activating mutation, S489F, in the interleukin-31 receptor alpha chain. Combined, these results suggest a role for glycosylated hotspot residues in regulating receptor signaling, mutation of which can lead to ligand-independent, uncontrolled activity and human disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Neutrophilic, ChronicHumansGlycosylationLigandsMutationReceptors, Colony-Stimulating FactorThreonineColony-Stimulating Factors

Stichwörter der Autor:innen

glycoproteinmass spectrometry (MS)mutagenesisneutrophilreceptor

Substanzen

LigandsReceptors, Colony-Stimulating FactorThreonineColony-Stimulating FactorsCSF3R protein, human

Autor:innen und Institutionen

  • Department of Bioengineering, Stanford University, Stanford, California, USA; Department of Chemistry and Sarafan ChEM-H, Stanford University, Stanford, California, USA.
  • Department of Chemistry and Sarafan ChEM-H, Stanford University, Stanford, California, USA.
  • Department of Bioengineering, Stanford University, Stanford, California, USA.
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
  • Department of Bioengineering, Stanford University, Stanford, California, USA; Department of Chemical Engineering, Stanford University, Stanford, California, USA. Electronic address: jennifer.cochran@stanford.edu.
  • Department of Chemistry and Sarafan ChEM-H, Stanford University, Stanford, California, USA; Howard Hughes Medical Institute, Stanford, California, USA. Electronic address: bertozzi@stanford.edu.

Förderung

  • NCI NIH HHS
  • Howard Hughes Medical Institute
  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • National Science Foundation
  • National Institutes of Health

Zitieren

APA

Hollander, M. J., Malaker, S. A., Riley, N. M., Perez, I., Abney, N. M., Gray, M. A., Maxson, J. E., Cochran, J. R., & Bertozzi, C. R. (2023). Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104755

Vancouver

Hollander MJ, Malaker SA, Riley NM, Perez I, Abney NM, Gray MA, et al. Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104755

BibTeX
@article{Hollander2023,
  author = {Hollander, Michael J and Malaker, Stacy A and Riley, Nicholas M and Perez, Idalia and Abney, Nayla M and Gray, Melissa A and Maxson, Julia E and Cochran, Jennifer R and Bertozzi, Carolyn R},
  title = {Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.104755}
}
Kostenlos starten →